Answer
Yes. BCR-ABL inhibitors can reactivate previous hepatitis B infection, occasionally causing severe liver disease. Hepatitis B testing is required before treatment.
Sources for this answer
- Bosutinib 400mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.